Barclays’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,000
Closed -$660K 5944
2015
Q3
$660K Sell
10,000
-5,000
-33% -$385K ﹤0.01% 3111
2015
Q2
$1.17M Hold
15,000
﹤0.01% 2736
2015
Q1
$1.06M Buy
+15,000
New +$962K ﹤0.01% 2912

Other funds holding ACHC

Barclays's ACHC Position: Q1 2026 in Review

Barclays reduced its Acadia Healthcare (ACHC) stake by 59% in Q1 2026, selling an estimated $3.29M and leaving 126,681 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Barclays first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.4M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Barclays held 126,681 shares of Acadia Healthcare worth $2.96M as of Q1 2026.
  • Barclays sold 181,715 Acadia Healthcare shares in Q1 2026, an estimated $3.29M.
  • Acadia Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2123 holding.
  • Barclays first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Acadia Healthcare position peaked at $46.4M in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.